deltatrials

Advanced, androgen receptor positive triple negative breast cancer Clinical Trials

Conditions / Advanced, androgen receptor positive triple negative breast cancer

Delta Trials records 1 clinical trial for Advanced, androgen receptor positive triple negative breast cancer in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 77 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.

Trial Status

1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
77
Study Locations

Browse by location (77 total)